PBGENE-PCSK9

N/A

Report date: 2023/12/15 08:45:50

Base Information

Drug NamePBGENE-PCSK9
Drug Alias NamePBGENEPCSK9
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionGene expression modulatorsProprotein convertase subtilisin kexin type 9 inhibitors
TargetsProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsHyperlipoproteinaemia type IIa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrecision Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrecision Biosciences Inc
Inactive CompaniesN/A
Active IndicationsHyperlipoproteinaemia type IIa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A